Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing.
about
Validation of functional imaging as a biomarker for radiation treatment responseThe use and misuse of positron emission tomography in lung cancer evaluationInfluence of rigid coregistration of PET and CT data on metabolic volumetry: a user's perspectiveMetabolic Tumor Volume Measured by F-18 FDG PET/CT can Further Stratify the Prognosis of Patients with Stage IV Non-Small Cell Lung Cancer.A pattern of early radiation-induced inflammatory cytokine expression is associated with lung toxicity in patients with non-small cell lung cancer.Functional and molecular image guidance in radiotherapy treatment planning optimization.Localization accuracy of the clinical target volume during image-guided radiotherapy of lung cancer.Changes in functional lung regions during the course of radiation therapy and their potential impact on lung dosimetry for non-small cell lung cancerGenerating lung tumor internal target volumes from 4D-PET maximum intensity projections.(18)F-FDG avid volumes on pre-radiotherapy FDG PET as boost target delineation in non-small cell lung cancer.Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer.Changes in global function and regional ventilation and perfusion on SPECT during the course of radiotherapy in patients with non-small-cell lung cancer.Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer.Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developmentsResponse assessment using 18F-FDG PET early in the course of radiotherapy correlates with survival in advanced-stage non-small cell lung cancerDANGER is involved in high glucose-induced radioresistance through inhibiting DAPK-mediated anoikis in non-small cell lung cancer.Predictive models for regional hepatic function based on 99mTc-IDA SPECT and local radiation dose for physiologic adaptive radiation therapyA comparison of amplitude-based and phase-based positron emission tomography gating algorithms for segmentation of internal target volumes of tumors subject to respiratory motion.Monitoring cancer therapy with PET: probably effective, but more research is needed.Natural growth and disease progression of non-small cell lung cancer evaluated with 18F-fluorodeoxyglucose PET/CT.An assessment of cone beam CT in the adaptive radiotherapy planning process for non-small-cell lung cancer patients.Lung cancer: Morphological and functional approach to screening, staging and treatment planning.PET and PET-CT in radiation treatment planning for lung cancer.Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription.Individualization of cancer treatment from radiotherapy perspective.New era of radiotherapy: an update in radiation-induced lung disease.Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical Trial.Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps.Biomechanical deformable image registration of longitudinal lung CT images using vessel information.Predictive treatment management: incorporating a predictive tumor response model into robust prospective treatment planning for non-small cell lung cancer.Technical Note: Estimation of lung tumor thickness from planar dual-energy kV images.A geometric atlas to predict lung tumor shrinkage for radiotherapy treatment planning.Role of interim 18F-FDG-PET/CT for the early prediction of clinical outcomes of Non-Small Cell Lung Cancer (NSCLC) during radiotherapy or chemo-radiotherapy. A systematic review.Adaptive radiation for lung cancer.A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation.Rebuttal from Prof. Kong and Dr. Rabatic.Dose escalation for locally advanced lung cancer using adaptive radiation therapy with simultaneous integrated volume-adapted boost.Optimizing global liver function in radiation therapy treatment planningMetabolic Tumor Volume on PET Reduced More than Gross Tumor Volume on CT during Radiotherapy in Patients with Non-Small Cell Lung Cancer Treated with 3DCRT or SBRT.Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancer.
P2860
Q26823165-F041C0F2-526B-44DF-9EB3-D9E94F5B2DBBQ27021838-F7F2F288-6C4E-4263-8791-1C74855EF03FQ30724225-0682B768-E489-4735-B001-9B75DA3CA6B1Q33704656-2B9A1C16-02E0-4F89-B796-D008954E7D21Q34302308-6B87AA68-B122-450E-B80F-422221C62FC9Q34706820-08259C8F-27A8-4CE9-92F7-B10F25E3B319Q35019496-D6E7E70E-8A8B-45B0-8833-D29200D42375Q35455018-3A583296-B9CE-4985-8BAC-65981965F7F0Q35462479-DFCCC9A3-24FF-40A5-97B7-704B3B580147Q35870847-87D723D2-80D3-4DD9-A34E-A3B50FDE0D7AQ35971034-66FC52FF-CB01-4F39-A07F-9BF3CBEB1797Q36054735-6777BA56-7577-4E4D-A96E-ED439BEF02F8Q36261387-B205542A-C081-4F0B-AEE6-8D70A041CC48Q36325435-6F2BEB4D-3CB3-4377-97F6-927FC339D31AQ36341962-7C9ADBC3-8D03-4EAF-BA3D-2A95F97F727FQ36916437-27E2A3F6-F02D-46D0-88E0-592D823017ABQ37009671-C472C45B-E553-4BE2-A2A3-FC61519AC043Q37226679-02751C28-B952-400E-B354-375CE53405C3Q37548246-205C8017-4045-4C79-B2ED-ED42E77E4E58Q37600536-8C0403CC-3BB9-402A-BAF9-24AF74212EB7Q37601059-6A408F10-F605-4212-A694-812B4E16E113Q37707376-F28728DF-C354-4985-A1C7-1D9968EF5F34Q37732292-7F41508D-2C8B-4E61-9ADA-05CD975DC86FQ37847721-FB41D9E3-57C0-4E21-BA64-3C7DE7449E35Q37989616-80434D58-A5EE-4275-B585-38C8E048DB98Q38087689-BEF43FB3-00E7-4A9F-BD50-FF0F12515EF4Q38376135-8C2141E0-1232-4743-B9D8-D216F392645EQ38413433-4F2A41BB-5326-418C-8924-2A83F3B140CEQ38856745-57F8F9A9-0486-4A19-9A81-52CF8B1EE2E1Q38903628-3FDA73F5-567E-430E-9CA6-848965C58B86Q38968508-13A59B16-7184-42A8-ADC2-70924CC003CAQ39029314-B56D2447-CABB-4151-BBA2-6D93EE09E06EQ39417217-6C5811FE-A776-48EE-A653-5E059BAD585DQ39841301-8E9BC8B3-65BC-49FF-A89B-AAE5DA6D3742Q40676879-ABA2976B-CCF6-4850-983E-0D48B9946792Q41081446-5D14A37A-8689-4294-AFAD-7090C7D0B3D3Q41110142-A99D8BE8-3F25-4F2C-86EE-133BD3E314EEQ41783193-3699C991-23F6-4C44-BD51-4126E0B93A2DQ42167591-E365D27B-F716-44C0-87C3-682D359FB692Q42232269-74966A91-AE51-4FCB-9296-B2FD94BFCE2E
P2860
Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Using fluorodeoxyglucose posit ...... ion and normal tissue sparing.
@ast
Using fluorodeoxyglucose posit ...... ion and normal tissue sparing.
@en
type
label
Using fluorodeoxyglucose posit ...... ion and normal tissue sparing.
@ast
Using fluorodeoxyglucose posit ...... ion and normal tissue sparing.
@en
prefLabel
Using fluorodeoxyglucose posit ...... ion and normal tissue sparing.
@ast
Using fluorodeoxyglucose posit ...... ion and normal tissue sparing.
@en
P2093
P2860
P1476
Using fluorodeoxyglucose posit ...... ion and normal tissue sparing.
@en
P2093
Feng-Ming Kong
James A Hayman
Milton Gross
Randall K Ten Haken
Shaneli Fernando
P2860
P304
P356
10.1016/J.IJROBP.2008.10.054
P407
P577
2009-03-01T00:00:00Z